EXATECAN | EXATECAN FAM-TRASTUZUMAB DERUXTECAN-NXKI | ANTINEOPLASTIC ANTIBODY-DRUG CONJUGATE (ADC) A TOPOISOMERASE INHIBITOR TREATMENT OF UNRESECTABLE OR METASTATIC HER2-POSITIVE BREAST CANCER INTRACELLULAR LINKER LEAVAGE BY LYSOSOMAL ENZYMES THE MEMBRANE-PERMEABLE DXD CAUSES DNA DAMAGE | INJECTION | Cmax 10.1 NANOMOLAR PPB 97 PERCENT Cl 19.2 LITER / HOUR HT 139.2 HOUR | TOPOISOMERASE | Unknown - more at DrugCentral | EMA ANSM (in French) Inxight Drugs Dailymed Drugs.com SIDER side effects Chemical Probes Portal ChEMBL BindingDB DrugBank |